Time to peak serum antibody response to influenza vaccine
- PMID: 7719904
- PMCID: PMC170112
- DOI: 10.1128/cdli.2.1.120-121.1995
Time to peak serum antibody response to influenza vaccine
Abstract
The time to the appearance of a peak serum antibody response to influenza virus vaccine is not clearly defined. We compared the most commonly used time intervals described in the literature--4 and 6 weeks after vaccination. We studied 118 elderly patients from three different geographic sites. The 1992 to 1993 trivalent inactivated influenza virus vaccine containing influenza virus A/Beijing/353/89 (H3N2), influenza virus A/Texas/36/91 (H1N1), and influenza virus B/Panama/45/90 was used. No statistically significant differences were found at the 4- and 6-week intervals after vaccination.
Similar articles
-
Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women.Clin Diagn Lab Immunol. 1994 Jan;1(1):16-20. doi: 10.1128/cdli.1.1.16-20.1994. Clin Diagn Lab Immunol. 1994. PMID: 7496915 Free PMC article. Clinical Trial.
-
Immune response of adults to sequential influenza vaccination.J Med Virol. 1984;14(2):169-75. doi: 10.1002/jmv.1890140211. J Med Virol. 1984. PMID: 6491643
-
[The evaluation of the reactogenicity and immunological activity of an inactivated 3-component influenza vaccine with an elevated hemagglutinin concentration in the inoculation dosage].Zh Mikrobiol Epidemiol Immunobiol. 1991 Jul;(7):58-61. Zh Mikrobiol Epidemiol Immunobiol. 1991. PMID: 1950267 Russian.
-
Decreased antibody response to influenza vaccine among nursing-home residents who received recalled vaccine--New York, 1996.MMWR Morb Mortal Wkly Rep. 1996 Dec 20;45(50):1100-2. MMWR Morb Mortal Wkly Rep. 1996. PMID: 8999309
-
Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.J Infect Dis. 1996 Feb;173(2):453-6. doi: 10.1093/infdis/173.2.453. J Infect Dis. 1996. PMID: 8568310 Clinical Trial.
Cited by
-
Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.Vaccines (Basel). 2024 Feb 20;12(3):219. doi: 10.3390/vaccines12030219. Vaccines (Basel). 2024. PMID: 38543853 Free PMC article.
-
Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.Eur Heart J. 2023 Feb 14;44(7):610-620. doi: 10.1093/eurheartj/ehac737. Eur Heart J. 2023. PMID: 36537199 Free PMC article.
-
Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning.J Infect Dis. 2019 Jun 5;220(1):12-19. doi: 10.1093/infdis/jiz055. J Infect Dis. 2019. PMID: 30722022 Free PMC article.
-
Time to earliest peak serum antibody response to influenza vaccine in the elderly.Clin Diagn Lab Immunol. 1997 Jul;4(4):491-2. doi: 10.1128/cdli.4.4.491-492.1997. Clin Diagn Lab Immunol. 1997. PMID: 9220171 Free PMC article.
-
The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination.Vaccines (Basel). 2021 Aug 2;9(8):846. doi: 10.3390/vaccines9080846. Vaccines (Basel). 2021. PMID: 34451971 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical